Skip to content
Screener

Quest Diagnostics DGX Total costs & expenses

Total costs & expenses at other companies

Opko Health logo
Opko HealthOPK
$170.55M-21.3%
Exagen Inc. logo
Exagen Inc.XGN
$13.62M+9.1%
Personalis, Inc. logo
Personalis, Inc.PSNL
$47.63M+24.4%
Natera, Inc. logo
Natera, Inc.NTRA
Agilent Technologies logo
Agilent TechnologiesA

Other financials

Income statement

See full
Revenue$3.0B+10.2%
Gross profit$1.0B+8.9%
Operating income$459.0M+4.8%
Net income$320.0M+13.5%
EPS (diluted)$2.84+15.0%

Balance sheet

See full
Cash & equivalents$626.0M+96.2%
Total debt$6.4B0.0%
Total equity$7.5B+4.0%
Total assets$16.9B+6.1%

Cash flow

See full
Operating cash flow$597.0M+9.7%
CapEx$138.0M+27.8%
Free cash flow$459.0M+5.3%

Valuation

See full
Market cap$25.72B+33.4%
Enterprise value$31.48B+24.2%
P/E24.2×+3.9×
P/S2.2×+0.4×

Profitability

See full
Gross margin33.1%+0.1pp
Operating margin14.1%+0.1pp
Net margin9.2%+0.2pp
FCF margin11.7%0.0pp

Returns & leverage

See full
Return on equity14.4%+0.7pp
Debt / equity0.8×0.0×
Current ratio1.6×+0.5×

Where this comes from

Reported directly by Quest Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The source filing: Quest Diagnostics’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:16 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001022079-26-000070
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Selling, general and administrative5294861,033962
Amortization of intangible assets38397578
Other operating expense (income), net1(20)3(18)
Total operating costs and expenses, net2,5842,3235,0804,629
Operating income459438858784
Other income (expense):
Interest expense, net(63)(67)(126)(134)
Other income, net16131410

Cover / Front Matter

FAQ

What is Quest Diagnostics's total costs & expenses?
Quest Diagnostics (DGX) reported total costs & expenses of $2.58B in Q2 2026.
How has Quest Diagnostics's total costs & expenses changed year-over-year?
Quest Diagnostics's total costs & expenses increased by 11.2% year-over-year, from $2.32B to $2.58B.
What is the long-term trend for Quest Diagnostics's total costs & expenses?
Over 4 years (2021 to 2025), Quest Diagnostics's total costs & expenses has grown at a 3.0% compound annual growth rate (CAGR), from $8.41B to $9.48B.
What does total costs & expenses mean?
This metric represents the aggregate sum of all operating costs incurred by the company to generate revenue, including cost of services, selling, general, and administrative expenses, and amortization of intangible assets. It serves as a comprehensive measure of the firm's operational cost structure and efficiency in managing its core business activities. Monitoring this figure allows investors to assess how effectively management controls overhead and production costs relative to top-line growth.

Ask your AI about Quest Diagnostics's total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude